Spero Therapeutics, Inc. Increase (Decrease) in Customer Advances and Deposits
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Customer Advances and Deposits of $465.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes
us-gaap:IncreaseDecreaseInCustomerAdvancesAndDeposits · last filed 2019-03-14
- Spero Therapeutics, Inc. increase (decrease) in customer advances and deposits for the quarter ending 2017-03-31 was $465.00K.
- Spero Therapeutics, Inc. increase (decrease) in customer advances and deposits for the quarter ending 2016-12-31 was $0.00.
- Spero Therapeutics, Inc. increase (decrease) in customer advances and deposits for fiscal 2016 was -$929.00K.
- Spero Therapeutics, Inc. increase (decrease) in customer advances and deposits for fiscal 2015 was -$470.00K.
| Period end | Increase (Decrease) in Customer Advances and Deposits 3 month | Increase (Decrease) in Customer Advances and Deposits 6 month | Increase (Decrease) in Customer Advances and Deposits 9 month | Increase (Decrease) in Customer Advances and Deposits 12 month |
|---|---|---|---|---|
| 2017-03-31 | $465.00K 10-Q · filed 2018-05-10 | $465.00K derived: sum of 2 quarters · filed 2019-03-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$929.00K 10-K · filed 2019-03-14 | ||
| 2016-09-30 | -$929.00K 10-Q · filed 2017-12-14 | |||
| 2015-12-31 | -$470.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |